Home Applications 021229 Application 021229
Type NDA
Sponsor ASTRAZENECA PHARMS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 PRILOSEC OTC OMEPRAZOLE MAGNESIUM TABLET, DELAYED RELEASE;ORAL EQ 20MG BASE Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021229-001 PRILOSEC OTC OMEPRAZOLE MAGNESIUM EQ 20MG BASE TABLET, DELAYED RELEASE / ORAL RLD 2003-06-20
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-10-28 04:53 UTC 2022-10 N021229-001 PRILOSEC OTC EQ 20MG BASE TABLET, DELAYED RELEASE / ORAL RLD, RS 2003-06-20 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N021229-001 PRILOSEC OTC EQ 20MG BASE TABLET, DELAYED RELEASE / ORAL RLD, RS 2003-06-20 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N021229-001 PRILOSEC OTC EQ 20MG BASE TABLET, DELAYED RELEASE / ORAL RLD, RS 2003-06-20 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N021229-001 PRILOSEC OTC EQ 20MG BASE TABLET, DELAYED RELEASE / ORAL RLD, RS 2003-06-20 a50c72e98297…
Observed Orange Book patent history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 2 · 21 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 11 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 37000-455 Prilosec OTC omeprazole magnesium The Procter & Gamble Manufacturing Company NDA Current 37000-455 Prilosec OTC omeprazole magnesium The Procter & Gamble Manufacturing Company NDA Current 37000-455 Prilosec OTC omeprazole magnesium The Procter & Gamble Manufacturing Company NDA Current 37000-455 Prilosec OTC omeprazole magnesium The Procter & Gamble Manufacturing Company NDA Current 37000-459 Prilosec OTC OMEPRAZOLE MAGNESIUM The Procter & Gamble Manufacturing Company NDA Current 37000-459 Prilosec OTC OMEPRAZOLE MAGNESIUM The Procter & Gamble Manufacturing Company NDA Current 37000-459 Prilosec OTC OMEPRAZOLE MAGNESIUM The Procter & Gamble Manufacturing Company NDA Current 37000-459 Prilosec OTC OMEPRAZOLE MAGNESIUM The Procter & Gamble Manufacturing Company NDA Current 70518-2167 Prilosec OTC omeprazole magnesium REMEDYREPACK INC. NDA Current 70518-2167 Prilosec OTC omeprazole magnesium REMEDYREPACK INC. NDA Current 70518-2167 Prilosec OTC omeprazole magnesium REMEDYREPACK INC. NDA Current